A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
National Cancer Institute (NCI)
Pfizer
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
AstraZeneca
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
BeOne Medicines
Neonc Technologies, Inc.
Radiopharm Theranostics, Ltd
NiKang Therapeutics, Inc.
MacroGenics
AstraZeneca
SystImmune Inc.
SN BioScience
ImmunityBio, Inc.
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
M.D. Anderson Cancer Center
NiKang Therapeutics, Inc.
Merck Sharp & Dohme LLC
Pfizer
Incyte Corporation
A2 Biotherapeutics Inc.
University of Virginia
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
OncoC4, Inc.
Klus Pharma Inc.
Theratechnologies
National Institutes of Health Clinical Center (CC)
Inspirna, Inc.
SOLTI Breast Cancer Research Group
Stanford University
Heronova Pharmaceuticals
Cofactor Genomics, Inc.
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
BeiGene
Carisma Therapeutics Inc
Tasly Biopharmaceuticals Co., Ltd.
Travera Inc